TCM Biotech International (ROCO:4169) Interest Expense : NT$-2.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TCM Biotech International's interest expense for the six months ended in Dec. 2023 was NT$ -1.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TCM Biotech International's Operating Income for the six months ended in Dec. 2023 was NT$ 11.2 Mil. TCM Biotech International's Interest Expense for the six months ended in Dec. 2023 was NT$ -1.3 Mil. TCM Biotech International's Interest Coverage for the quarter that ended in Dec. 2023 was 8.78. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TCM Biotech International Interest Expense Historical Data

The historical data trend for TCM Biotech International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Interest Expense Chart

TCM Biotech International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-2.20

-1.95

-1.97

-2.39

-2.77

TCM Biotech International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-1.04	-1.09	-1.30	-1.49	-1.28

TCM Biotech International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.8 Mil.

TCM Biotech International (ROCO:4169) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TCM Biotech International's Interest Expense for the six months ended in Dec. 2023 was NT$-1.3 Mil. Its Operating Income for the six months ended in Dec. 2023 was NT$11.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was NT$64.5 Mil.

TCM Biotech International's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	11.22	/	-1.278
	=	8.78

The higher the ratio, the stronger the company's financial strength is.

TCM Biotech International (ROCO:4169) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221

Website

http://www.tcmbio.com

TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines